| 中国学者近期发表的论文 |
|---|
| 1. | Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
Author: Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, Mao YP, Liu LZ, Li L, Lin AH, Ma J.
Journal: Radiother Oncol. 2012 Sep;104(3):294-9. doi: 10.1016/j.radonc.2012.09.001. Epub 2012 Sep 19. | | 2. | A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
Author: Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G.
Journal: Radiother Oncol. 2012 Sep;104(3):286-93. doi: 10.1016/j.radonc.2012.08.013. Epub 2012 Sep 17. | | 3. | A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection.
Author: Zhu WG, Xua DF, Pu J, Zong CD, Li T, Tao GZ, Ji FZ, Zhou XL, Han JH, Wang CS, Yu CH, Yi JG, Su XL, Ding JX.
Journal: Radiother Oncol. 2012 Sep;104(3):361-6. doi: 10.1016/j.radonc.2012.08.024. Epub 2012 Sep 14. | | 4. | Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy.
Author: Zhang AM, Fan Y, Wang XX, Xie QC, Sun JG, Chen ZT, Zhu B.
Journal: Radiother Oncol. 2012 Sep;104(3):279-85. doi: 10.1016/j.radonc.2012.08.022. Epub 2012 Sep 13. | | 5. | The battle against nasopharyngeal cancer.
Author: Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH.
Journal: Radiother Oncol. 2012 Sep;104(3):272-8. doi: 10.1016/j.radonc.2012.08.001. Epub 2012 Aug 30. | | 6. | Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo.
Author: Sun X, Xing L, Deng X, Hsiao HT, Manami A, Koutcher JA, Clifton Ling C, Li GC.
Journal: Radiother Oncol. 2012 Oct;105(1):57-63. doi: 10.1016/j.radonc.2012.07.011. Epub 2012 Aug 29. | | 7. | G2 checkpoint abrogator abates the antagonistic interaction between antimicrotubule drugs and radiation therapy.
Author: Sui M, Zhang H, Di X, Chang J, Shen Y, Fan W.
Journal: Radiother Oncol. 2012 Aug;104(2):243-8. doi: 10.1016/j.radonc.2012.04.021. Epub 2012 Jun 9. | | 8. | A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients.
Author: Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL.
Journal: Radiother Oncol. 2012 Sep;104(3):317-23. doi: 10.1016/j.radonc.2012.03.013. Epub 2012 Apr 30. | | 9. | Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Author: Loong HH, Ma BB, Leung SF, Mo F, Hui EP, Kam MK, Chan SL, Yu BK, Chan AT.
Journal: Radiother Oncol. 2012 Sep;104(3):300-4. doi: 10.1016/j.radonc.2011.12.022. Epub 2012 Jan 31. | | 10. | Hypofraction radiotherapy of liver tumor using cone beam computed tomography guidance combined with active breath control by long breath-holding.
Author: Zhong R, Wang J, Jiang X, He Y, Zhang H, Chen N, Bai S, Xu F.
Journal: Radiother Oncol. 2012 Sep;104(3):379-85. doi: 10.1016/j.radonc.2011.11.007. Epub 2012 Jan 17. |
|
